UK to evaluate congenital hip screening:
This article was originally published in Clinica
A UK government committee is to evaluate the cost-effectiveness of current and alternative strategies for the neonatal screening programme for congenital dislocation of the hip. This follows a report from the Medical Research Council which has questioned the effectiveness of current screening policy which is based on physical examination. The national screening committee will discuss the use of ultrasound which, under present guidelines, is not employed for routine screening in the UK. The evaluatory study will take place over a six-month period, with policy change proposals expected by the end of 1999.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.